InsiderTrades

Form 4/A for NHC NATIONAL HEALTHCARE CORP

Accepted 2023-11-29 00:00:00 ET · period of report 2023-11-17 · accession 0001437749-23-033181 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DA 2023-11-29 2023-11-17 NHC Flatt Stephen Fowler CEO, Dir G - Gift $0.00 -800 55.9K -1% $0
DA 2023-11-29 2023-11-21 NHC Flatt Stephen Fowler CEO, Dir F - Tax $77.33 -4,261 56.3K -7% -$329.5K
DA 2023-11-29 2023-11-21 NHC Flatt Stephen Fowler CEO, Dir M - OptEx $63.96 +4,733 60.6K +8% +$302.7K
DA 2023-11-29 2023-11-21 NHC Flatt Stephen Fowler CEO, Dir M - OptEx $0.00 -4,733 9,467 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-11-17 G D 800 $0.00 55,868 D — — (F4) The date of the reported gifting transaction was previously reported as November 16, 2023 and is corrected here to be November 17, 2023.
2 Common Common Stock 2023-11-21 F D 4,261 $77.33 56,340 D — — (F2) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. (F3) Total amount of shares beneficially owned following transactions reported on this form.
3 Common Common Stock 2023-11-21 M A 4,733 $63.96 60,601 D — — (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
4 Derivative Option to Purchase Common Stock 2023-11-21 M D 4,733 $0.00 9,467 D $63.96 · 2023-02-18 to 2027-02-18 14,200 Common Stock (F1) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).